Putin instructed Murashko to deal with the shortage of devices for diabetics
[ad_1]
Russian President Vladimir Putin, during a meeting with the government, drew attention to the shortage of glucose monitoring devices. He gave Health Minister Mikhail Murashko a week to think through measures to improve the situation with the devices necessary for the treatment of diabetes.
The head of the executive committee of the All-Russian Popular Front party, Mikhail Kuznetsov, spoke at the meeting about the problems that Russians who have been diagnosed with diabetes are currently facing. In particular, he noted the lack of continuous glucose monitoring devices.
After Mr. Kuznetsov’s speech, Vladimir Putin addressed the head of the Ministry of Health: “Look at the information that the Popular Front has received, and in a week you will report to me again what and how you plan to do in the near future to change the situation for the better.” , in the direction we need.” The president’s words are quoted by TASS.
Speaking about the treatment of diabetes in Russia, Mikhail Murashko noted that domestic drugs with the active substance semaglutide are currently undergoing the registration procedure. Medicines containing semaglutide are also used to treat diabetes mellitus. “I would like to note that today an original drug for the treatment of type 2 diabetes has been developed by domestic manufacturers, and domestic drugs whose active ingredient is semaglutide are undergoing the registration procedure. They will replace a foreign drug on the market,” said Mr. Murashko.
Last week, Kommersant spoke about interruptions in the supply of Medtronic glucose monitoring devices to Russia. According to Natalya Mokrysheva, director of the National Medical Research Center for Endocrinology, the disruptions began after some of the components for the Medtronic system were included in the US restrictive list. So far, products from the American Abbott remain on the market, but they are not intended for diabetic children under four years of age.
Read more about the market situation in the Kommersant article. “Glucose was prescribed a dual purpose”.
[ad_2]
Source link
